Acute Management of Hypertension Following Intracerebral Hemorrhage

Area of Science:

• Neurology
• Critical Care Medicine
• Pharmacology

Background:

• Intracerebral hemorrhage (ICH) accounts for 15% of US strokes, with high mortality and stagnant outcomes for decades.
• The acute hypertensive response post-ICH worsens bleeding and predicts mortality.
• Historically, rapid blood pressure reduction was feared to cause ischemia, but is now considered safe in select patients.

Purpose of the Study:

• To review current literature on blood pressure management following ICH.
• To inform nurses about antihypertensive and other medications used for acute SBP reduction in ICH patients.

Main Methods:

• Literature review of studies on blood pressure control in ICH.
• Focus on intravenous and oral antihypertensive agents available in the US.
• Inclusion of non-antihypertensive medications that lower SBP in acute ICH settings.

Main Results:

• The review synthesizes data on the safety and efficacy of various medications for lowering SBP after ICH.
• Identifies specific patient populations that may benefit from acute SBP reduction.
• Highlights both standard antihypertensives and other agents used in clinical practice.

Conclusions:

• Acute blood pressure management is crucial for improving outcomes in ICH.
• Nurses require up-to-date information on pharmacological strategies for SBP control in ICH.
• Evidence supports the judicious use of specific medications to lower SBP and mitigate ICH expansion.